Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma

International Journal of Cancer

Volumn 132, Issue 2, 2013, Pages 297-307

  Conesa Zamora, Pablo ^a   García Solano, José ^a   García García, Francisco ^b   Turpin, María Del Carmen ^a,c   Trujillo Santos, Javier ^d   Torres Moreno, Daniel ^a   Oviedo Ramírez, Isabel ^a   Carbonell Muñoz, Rosa ^d   Muñoz Delgado, Encarnaciõn ^e   Rodriguez Braun, Edith ^d   Conesa, Ana ^b   Pérez Guillermo, Miguel ^a  

^a Santa Lucia University Hospital HGUSL   (Spain)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^c UNIVERSIDAD FRANCISCO DE VITORIA   (Spain)

^d HGUSL   (Spain)

^e UNIVERSITY OF MURCIA   (Spain)

Author keywords

colorectal cancer; fascin; hippocalcin; microarray analysis; microsatellite instability; serrated adenocarcinoma

Indexed keywords

BETA DYSTROGLYCAN; BIOLOGICAL MARKER; FASCIN1; HIPPOCALCIN; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CELL VACUOLE; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL SERRATED ADENOCARCINOMA; CONTROLLED STUDY; CYTOSKELETON; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MICROSATELLITE INSTABILITY; MORPHOGENESIS; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION; HIPPOCALCIN; HUMANS; MALE; MICROFILAMENT PROTEINS; MICROSATELLITE INSTABILITY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEURONAL APOPTOSIS-INHIBITORY PROTEIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84869489749     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27674     Document Type: Article

References (35)

1. Hamilton SR, Bosman FT, Boffetta P, et al. Carcinoma of the colon and rectum. In:, Bosman FT, Carneiro F, Hruban RH, et al., eds. WHO classification of tumors of the digestive system. Lyon: IARC, 2010. 134-46.
2. Mäkinen MJ, George SM, Jernvall P, et al. Colorectal carcinoma associated with serrated adenoma - prevalence, histological features, and prognosis. J Pathol 2001; 193: 286-94.
3. Tuppurainen K, Mäkinen JM, Junttila O, et al. Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J Pathol 2005; 207: 285-94.
4. García-Solano J, Pérez-Guillermo M, Conesa-Zamora P, et al. Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum Pathol 2010; 41: 1359-68.
5. Mäkinen MJ,. Colorectal serrated adenocarcinoma. Histopathology 2007; 50: 131-50.
6. García-Solano J, Conesa-Zamora P, Trujillo-Santos J, et al. Tumor budding and other prognostic pathological features at invasive margins in serrated colorectal adenocarcinoma: a comparative study with conventional carcinoma. Histopathology 2011; 59: 1046-56.
7. García-Solano J, Conesa-Zamora P, Trujillo-Santos J, et al. Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma. Hum Pathol, 2012; 43: 1094-102.
8. García-Solano J, Conesa-Zamora P, Carbonell P, et al. Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas. Int J Cancer, doi: 10.1002/ijc.27454.
9. Stefanius K, Ylitalo L, Tuomisto A, et al. Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma. Histopathology 2011; 58: 679-692.
10. Huang CS, Farraye FA, Yang S, et al. The clinical significance of serrated polyps. Am J Gastroenterol 2011; 106: 229-40.
11. O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006; 30: 1491-501.
12. Laiho P, Kokko A, Vanharanta S, et al. Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis. Oncogene 2007; 26: 312-20.
13. Redston M,. Epithelial neoplasms of the large intestine. In:, Odze RD, Goldblum JR, Crawford JM, eds. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philadelphia: Saunders, 2004. 441-72.
14. Bellizzi AM, Frankel WL,. Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv Anat Pathol 2009; 16: 405-17.
15. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995; 57: 289-300.
16. Al-Shahrour F, Carbonell J, Minguez P, et al. Babelomics: advanced functional profiling of transcriptomics, proteomics and genomics experiments. Nucleic Acids Res 2008; 36: W341-W346.
17. Jiang X, Rieder S, Giese NA, et al. Reduced alpha-dystroglycan expression correlates with shortened patient survival in pancreatic cancer. J Surg Res 2011; 171: 120-126.
18. Mercer EA, Korhonen L, Skoglösa Y, et al. NAIP interacts with hippocalcin and protects neurons against calcium-induced cell death through caspase-3-dependent and -independent pathways. EMBO J 2000; 19: 3597-607.
19. Kureishy N, Sapountzi V, Prag S, et al. Fascins, and their roles in cell structure and function. Bioessays 2002; 24: 350-61.
20. Hashimoto Y, Skacel M, Adams JC,. Roles of fascin in human carcinoma motility and signalling: prospects for a novel biomarker. Int J Biochem Cell Biol 2005; 37: 1787-804.
21. Qualtrough D, Singh K, Banu N, et al. The actin-bundling protein fascin is over-expressed in colorectal adenomas and promotes motility in adenoma cells in vitro. Br J Cancer 2009; 101: 1124-9.
22. Sarriõ D, Rodriguez-Pinilla SM, Hardisson D, et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008; 68: 989-97.
23. Hashimoto Y, Skacel M, Lavery IC, et al. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer 2006; 6: 241.
24. Chen L, Yang S, Jakoncic J, et al. Migrastatin analogues target fascin to block tumour metastasis. Nature 2010; 464: 1062-6.
25. Kobayashi M, Takamatsu K, Saitoh S, et al. Myristoylation of hippocalcin is linked to its calcium-dependent membrane association properties. J Biol Chem 1993; 268: 18898-904.
26. Callaghan DW, Tepikin AV, Burgoyne RD,. Dynamics and calcium sensitivity of the Ca2+/myristoyl switch protein hippocalcin in living cells. J Cell Biol 2003; 163: 715-21.
27. Miyagawa Y, Ohguro H, Odagiri H, et al. Aberrantly expressed recoverin is functionally associated with G-protein-coupled receptor kinases in cancer cell lines. Biochem Biophys Res Commun 2003; 300: 669-73.
28. Lan MS, Breslin MB,. Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation. FASEB J 2009; 23: 2024-33.
29. Posorski N, Kaemmerer D, Ernst G, et al. Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases. Clin Exp Metastasis 2011; 28: 637-47.
30. Cavallaro U, Christofori G,. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004; 4: 118-32.
31. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-8.
32. Jenkins MA, Hayashi S, O'Shea AM, et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 2007; 133: 48-56.
33. Greenson JK, Huang SC, Herron C, et al. Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol 2009; 33: 126-33.
34. Hyde A, Fontaine D, Stuckless S, et al. A histology-based model for predicting microsatellite instability in colorectal cancers. Am J Surg Pathol 2010; 34: 1820-9.
35. Bessa X, Alenda C, Paya A, et al. Validation microsatellite path score in a population-based cohort of patients with colorectal cancer. J Clin Oncol 2011; 29: 3374-80.